Advertisement
News
Subscribe to MDT Magazine News

A Pacemaker the Size of a Tic Tac

February 27, 2011 7:34 pm | by Massachusetts Institute of Technology | Comments

Medtronic is using microelectronics to make a pacemaker so small it can be injected.

TOPICS:

Canada's role grows amid looming world water shortages in some places, more flooding in others

February 27, 2011 10:34 am | by EurekAlert | Comments

(Canadian Water Network) With a view to UN World Water Day, March 22, experts convening in Ottawa Feb. 28 to March 3 say water-rich Canada and water management experts have growing importance as countries elsewhere brace for more frequent drought, flood and unsafe water problems...

TOPICS:

Adeona Mourns the Passing of David A. Newsome, M.D., Senior Vice President of Research & Development

February 27, 2011 1:35 am | by Bio-Medicine.Org | Comments

ANN ARBOR, Mich., Feb. 27, 2011 /- With deep regret, Adeona Pharmaceuticals, Inc. (Amex: AEN ), announced today the passing of its Senior Vice President of Research & Development, David A. Newsome, M.D. Dr. Newsome invented and developed ZincMonoCysteine and was the first person to...

TOPICS:
Advertisement

FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder

February 25, 2011 10:36 pm | by Bio-Medicine.Org | Comments

PHILADELPHIA, Feb. 25, 2011 /- GlaxoSmithKline (NYSE: GSK ) today announced that the United States Food and Drug Administration (FDA) granted full approval for PROMACTA® (eltrombopag), an oral tablet that can raise platelet counts in patients with the rare blood disorder chronic...

TOPICS:

Radio-guided surgery a safe and simple way to remove potentially cancerous nodules in the lung

February 25, 2011 10:33 pm | by EurekAlert | Comments

(European Society for Medical Oncology) Using tiny spheres of radioactive liquid to guide surgeons as they remove potentially cancerous material in the lungs is safe and more effective than other techniques, Italian researchers report.

TOPICS:

Erlotinib effective and with fewer side-effects after first-line treatment

February 25, 2011 10:33 pm | by EurekAlert | Comments

(European Society for Medical Oncology) The targeted cancer drug erlotinib has comparable efficacy to chemotherapy, and is better tolerated, in hard-to-treat cases where a patient's cancer has progressed quickly after treatment with first-line therapy, the results of a new phase III trial show.

TOPICS:

Oxford Instruments and ITRI jointly establish research center for WLP and LED packaging development

February 25, 2011 5:37 pm | by I-Micronews | Comments

Oxford Instruments and Industry Technology Research Institute (ITRI) have jointly set up a research center for wafer-level packaging (WLP) process in high-brightness LED and micro structure technology.

Direct Grid Technologies micro-inverter in volume production

February 25, 2011 5:36 pm | by I-Micronews | Comments

After a rigorous and demanding beta and pilot production period, Direct Grid is now shipping its DGM‐460 micro inverter in volume for lead customers in North America.

Advertisement

Defense Department awards Tricare deal to Humana(2)

February 25, 2011 3:47 pm | by The Associated Press | Comments

Humana will continue providing health care to military members and their families in the South.The company announced Friday that the Department of Defense re-evaluated an earlier decision to award the contract for Tricare health coverage to UnitedHealth. A congressional agency supported...

Defense Department awards Tricare deal to Humana

February 25, 2011 3:46 pm | Comments

Humana will continue providing health care to military members and their families in the South.The company announced Friday that the Department of Defense re-evaluated an earlier decision to award the contract for Tricare health coverage to UnitedHealth. A congressional agency supported...

Svelte 30: Recall - Undeclared Drug Ingredient

February 25, 2011 1:32 pm | by U.S. Food & Drug Administration | Comments

Product marketed as a dietary supplement contains sibutramine, which may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.

TOPICS:

EU Patent System Moves Forward But Still Facing Difficulties

February 25, 2011 1:32 pm | by U.S. Food & Drug Administration | Comments

With the European Parliament’s consent for enhanced cooperation, a common EU patent system may become a reality.

TOPICS:

Medtronic Is Cutting Staff, Selling Unit, in & #8216;Soft & #8217; Times

February 25, 2011 1:31 pm | by U.S. Food & Drug Administration | Comments

Medtronic is eliminating up to 2,000 positions during the third quarter as part of a major restructuring it blames on softer markets.

TOPICS:

Fitch lowers outlook on Quest Diagnostics

February 25, 2011 12:45 pm | by The Associated Press | Comments

Fitch Ratings said Friday it is lowering its outlook on Quest Diagnostics Inc., citing the medical lab operator's upcoming purchase of a diagnostics business and other spending.The firm now has a negative outlook on Quest's credit, meaning a downgrade of its rating is more likely than an...

Aetna chairman to retire on April 8

February 25, 2011 10:45 am | by The Associated Press | Comments

Managed care company Aetna Inc. said Friday that Chairman Ronald A. Williams plans to retire on April 8, a move first announced in October.President and CEO Mark T. Bertolini will succeed Williams. Bertolini, 54, already assumed the chief executive position previously held by Williams in...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading